Dopamine supersensitivity psychosis

Dopamine Supersensitivity Psychosis (DSP) is a condition that is characterized by an increased sensitivity to the effects of dopamine in the brain. This condition is often associated with the long-term use of antipsychotic medications, which are commonly used to treat conditions such as schizophrenia and bipolar disorder.

Overview

Dopamine Supersensitivity Psychosis is a controversial concept in psychiatry. It is proposed to occur as a result of prolonged treatment with antipsychotic drugs, which block the D2 receptor, a type of dopamine receptor in the brain. Over time, the brain may respond to this blockage by increasing the number and sensitivity of D2 receptors, leading to an increased response to dopamine. This can result in a worsening of psychotic symptoms, even in the absence of the original disease.

Symptoms

The symptoms of Dopamine Supersensitivity Psychosis can vary widely, but often include an increase in the severity of psychotic symptoms, such as hallucinations, delusions, and paranoia. These symptoms may become resistant to treatment with antipsychotic medications. Other symptoms can include motor disturbances such as tardive dyskinesia, a condition characterized by involuntary, repetitive body movements.

Treatment

The treatment of Dopamine Supersensitivity Psychosis can be challenging, as the condition is often resistant to traditional antipsychotic medications. Some studies suggest that switching to a different type of antipsychotic medication, or reducing the dosage, may be beneficial. However, more research is needed to determine the most effective treatment strategies.

See also

• Dopamine
• Antipsychotic
• Schizophrenia
• Bipolar disorder
• Tardive dyskinesia

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!